BioSpace News Archive

Nelipak® Corporation (“Nelipak”), a global leader in rigid and flexible packaging for the medical device and pharmaceutical sectors, announced today that Pat Chambliss has been named the company’s Chief Executive Officer. Chambliss, current President and Chief Operating Officer of Nelipak, brings to the Chief Executive Officer role an extensive track record of senior leadership experience in the packaging industry, including previous roles at P

GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company’s proprietary NK cell engager (TriKE™) technology platform announces that it will be holding a shareholder update call on Thursday, Jan

CVS Health Corporation announced that its board of directors has approved a quarterly dividend of $0.50 per share on the corporation’s common stock.

According to a new nationwide survey, the 34 million Americans living with diabetes face unique, acute and intensified challenges to their health as a result of the COVID-19 pandemic – challenges that may increase their COVID risk for complications.

Passage Bio, Inc. announced that Bruce Goldsmith, Ph.D., president and chief executive officer will present a company overview at the J.P Morgan 39th Annual Healthcare Conference being held virtually on Monday, January 11, 2021 at 7:30am ET.

Rubius Therapeutics, Inc.announced that Pablo J. Cagnoni, M.D., president and chief executive officer, will present at the virtual 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021, at 8:20 a.m. ET.

Scholar Rock announced that management will present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 5:20 p.m. ET.

Natus Medical Incorporated (NASDAQ: NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced today that the Company will release its 2020 fourth quarter financial results after the close of the market on Thursday, February 25th.

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, the Company’s Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright VIRTUAL BioConnect Conference,

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive Chief Executive Officer, J. Christopher Barry will present at the 39 th Annual Virtual J.P. Morgan Healthcare Conference on Wednesd